T-MSIS provider-level spending data, Jan 2018 – Dec 2024
Thyroid stimulating hormone (TSH)
Total Paid
$727.4M
$727,430,856
Beneficiaries
82.4M
82,359,663
Avg $/Claim
$8
Utilization
1.1 claims/bene
1,829 providers
Each dot is a state. X = average cost per claim. Y = total spending.
Drag to zoom into a region
| # | State | Total Paid▼ | Avg $/Claim | Claims | Beneficiaries | Providers |
|---|---|---|---|---|---|---|
| 1 | CA | $100.8M | $6 | 17,996,611 | 17,589,858 | 1,363 |
| 2 | OH | $58.5M | $11 | 5,235,085 | 4,742,141 | 245 |
| 3 | PR | $50.9M | $15 | 3,390,355 | 3,122,387 | 766 |
| 4 | NJ | $43.6M | $5 | 8,140,847 | 7,808,180 | 137 |
| 5 | IL | $39.4M | $10 | 3,813,282 | 3,457,818 | 532 |
| 6 | NC | $38.9M | $8 | 4,841,329 | 4,518,231 | 208 |
| 7 | NY | $33.6M | $8 | 4,304,555 | 4,218,655 | 411 |
| 8 | MA | $25.6M | $7 | 3,716,900 | 3,546,013 | 186 |
| 9 | KY | $24.2M | $15 | 1,629,428 | 1,490,158 | 178 |
| 10 | MI | $22.1M | $7 | 2,986,292 | 2,919,025 | 230 |
| 11 | TX | $21.3M | $7 | 3,184,267 | 3,018,379 | 484 |
| 12 | FL | $20.0M | $3 | 5,742,131 | 4,715,642 | 477 |
| 13 | WA | $19.4M | $11 | 1,730,557 | 1,657,283 | 150 |
| 14 | AL | $16.3M | $12 | 1,376,541 | 1,191,715 | 131 |
| 15 | WI | $15.3M | $13 | 1,159,279 | 1,041,510 | 202 |
| 16 | PA | $15.2M | $14 | 1,111,514 | 1,070,687 | 263 |
| 17 | WV | $12.3M | $23 | 542,784 | 489,580 | 95 |
| 18 | NM | $11.0M | $17 | 661,068 | 642,082 | 83 |
| 19 | KS | $10.9M | $11 | 977,241 | 937,875 | 105 |
| 20 | OR | $10.2M | $15 | 667,682 | 629,069 | 95 |
| 21 | AK | $8.6M | $56 | 155,041 | 144,503 | 37 |
| 22 | HI | $8.3M | $26 | 317,896 | 304,789 | 22 |
| 23 | RI | $7.8M | $31 | 254,833 | 216,160 | 95 |
| 24 | GA | $7.7M | $9 | 866,517 | 792,834 | 47 |
| 25 | CO | $7.5M | $13 | 569,448 | 522,135 | 126 |
56 rows · Page 1 of 3